ZVRA earnings date and last-quarter result: last quarter beat, P/E 5.57. Updated 2026-07-23.
Zevra Therapeutics (ZVRA) Research Hub
Zevra Therapeutics (ZVRA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 9.53 USD (-2.85%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 5.57, market cap 0.72B. This hub links to the full technical, earnings and options research available for ZVRA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 9.53 USD (-2.85%) |
| 52-week range | 9.1 USD – 14.96 USD |
| Trend regime | Range |
| 14-day RSI | 34.3 (Bearish) |
| Trailing P/E | 5.57 |
| Market cap | 0.72B |
| Dividend yield | 0.00% |
Available research for ZVRA
Covered Call on ZVRA: how it works, illustrative setup around the real 9.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ZVRA: how it works, illustrative setup around the real 9.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ZVRA: how it works, illustrative setup around the real 9.53 USD price, max profit/loss, breakeven and when to use it. Educational.
ZVRA technical analysis: range, last 9.53 USD, RSI 34.3, 52w range 9.1 USD–14.96 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ZVRA in?
Zevra Therapeutics (ZVRA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ZVRA in an uptrend or downtrend?
As of 2026-10-26, ZVRA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ZVRA's trailing P/E ratio?
ZVRA's trailing P/E is 5.57, with a market cap of 0.72B. See the earnings research page for full valuation detail.